DHG Pharmaceutical JSC (HOSE:DHG)
Vietnam flag Vietnam · Delayed Price · Currency is VND
83,800
-1,000 (-1.18%)
At close: Nov 3, 2026

DHG Pharmaceutical JSC Income Statement

Millions VND. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5,326,9575,266,9634,884,8685,015,3954,676,0164,003,170
Revenue Growth
6.90%7.82%-2.60%7.26%16.81%6.59%
Cost of Revenue
2,706,3982,760,5942,747,1022,671,8502,418,5212,082,260
Gross Profit
2,620,5602,506,3692,137,7662,343,5452,257,4951,920,911
Selling, General & Admin
1,646,5241,553,7001,217,4911,291,2641,181,4171,060,127
Operating Expenses
1,646,5241,553,7001,217,4911,291,2641,181,4171,060,127
Operating Income
974,036952,669920,2761,052,2811,076,078860,784
Interest Expense
-2,999-25,635-24,811-29,530-12,559-12,080
Interest & Investment Income
106,824123,012138,160202,173120,337114,306
Currency Exchange Gain (Loss)
2,744-578.16-2,5145,5803,5874,160
Other Non Operating Income (Expenses)
-51,891-60,631-127,857-73,082-89,517-93,955
EBT Excluding Unusual Items
1,028,714988,837903,2541,157,4231,097,926873,214
Gain (Loss) on Sale of Investments
-525192.5262.5315-772.55274.7
Gain (Loss) on Sale of Assets
-2,914-2,430967.731,4372,518-7,999
Other Unusual Items
-----58.33-1,488
Pretax Income
1,025,275986,599904,4851,159,1741,099,613864,002
Income Tax Expense
172,859134,245125,564108,512111,15987,717
Earnings From Continuing Operations
852,416852,354778,9201,050,663988,455776,285
Minority Interest in Earnings
-----934.93
Net Income
852,416852,354778,9201,050,663988,455777,220
Preferred Dividends & Other Adjustments
27,57227,57125,36833,52031,65429,317
Net Income to Common
824,844824,783753,5531,017,143956,801747,903
Net Income Growth
-7.62%9.45%-25.91%6.31%27.93%5.09%
Shares Outstanding (Basic)
131131131131131131
Shares Outstanding (Diluted)
131131131131131131
Shares Change
------
EPS (Basic)
6308.756308.295763.487779.537318.015720.27
EPS (Diluted)
6308.756308.295763.487779.537318.015720.27
EPS Growth
-7.62%9.45%-25.91%6.31%27.93%5.09%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
619,8531,181,8311,228,879-246,171667,293427,882
Free Cash Flow Per Share
4740.909039.139398.97-1882.825103.733272.62
Dividend Per Share
5000.0005000.00010000.0007500.0003500.0003500.000
Dividend Growth
-16.67%-50.00%33.33%114.29%0%-12.50%
Gross Margin
49.19%47.59%43.76%46.73%48.28%47.98%
Operating Margin
18.29%18.09%18.84%20.98%23.01%21.50%
Profit Margin
15.48%15.66%15.43%20.28%20.46%18.68%
Free Cash Flow Margin
11.64%22.44%25.16%-4.91%14.27%10.69%
EBITDA
1,091,2451,070,6981,089,9711,140,9851,157,079943,348
EBITDA Margin
20.48%20.33%22.31%22.75%24.75%23.57%
D&A For EBITDA
117,210118,029169,69588,70481,00182,564
EBIT
974,036952,669920,2761,052,2811,076,078860,784
EBIT Margin
18.29%18.09%18.84%20.98%23.01%21.50%
Effective Tax Rate
16.86%13.61%13.88%9.36%10.11%10.15%
Revenue as Reported
5,326,9575,266,9634,884,8685,015,3954,676,0164,003,170
Advertising Expenses
-166,41061,742128,162138,011138,095